Allopurinol, a drug normally prescribed for gout, is being used to test for
tumours in patients at high risk of developing cancer due to genetic or
environmental factors. Developed by researchers at Johns Hopkins University in
Baltimore, Maryland, the test uses allopurinol to temporarily slow DNA
production in cancer cells, causing some components of DNA鈥攃alled
pyrimidines鈥攖o accumulate in the blood. These can be detected in the
patient鈥檚 urine.
More from New Scientist
Explore the latest news, articles and features
Environment
Galapagos corals suggest climate change drives stronger El Ni帽os
News
Life
Astonishing whale feeding frenzy seen off the eastern coast of Greenland
News
Environment
Octopuses released into Adriatic Sea to tackle invasive crabs
News
Technology
Driving data can predict crash black spots before accidents happen
News
Popular articles
Trending New Scientist articles